Warning: Invalid argument supplied for foreach() in /nfs/c12/h06/mnt/215825/domains/gcaglobal.com/html/wp-content/themes/gca-altium/template-blocks/single-transaction.php on line 20

Transaction

Deal Type

M&A

Deal Value

$75M

Deal Status

Closed

GCA Advises Takara Bio USA Holdings, Inc. on Its Acquisition of Rubicon Genomics, Inc.

We are pleased to announce that on January 17, 2017, our client, Takara Bio USA Holdings, Inc., completed the acquisition of Rubicon Genomics, Inc.

Takara Bio USA Holdings, Inc. is a US-based, wholly owned subsidiary of Takara Bio Inc., a leading global biotechnology and life science company headquartered in Shiga, Japan. Rubicon Genomics, Inc., headquartered in Ann Arbor, Michigan, is a leading provider of pre-analytical library preparation kits that increase the accuracy, efficiency and speed of genomic analysis.

The acquisition will allow the Takara Bio Group (which includes Takara Bio Inc., Takara Bio USA, Inc. and other Takara Bio affiliates) to augment and expand its worldwide commercial offerings in next generation sequencing sample preparation and expand into new markets.

The transaction is subject to customary closing conditions.

GCA acted as exclusive financial advisor to Takara Bio USA Holdings, Inc. in connection with this transaction.

All Transactions